Advertisement

Pharmacy

In the U.S., patients spend more on hospital care and clinical services than they do on prescription drugs, yet pharmaceutical companies often pocket more of the money than in other parts of the industry, including most insurers and health systems.…

Coherus BioSciences plans to price its biosimilar of Amgen's Neulasta, an infection-fighting treatment, at $4,175 per unit, according to Reuters. This is a 33 percent discount off the price of the brand name drug.

Japanese drugmaker Takeda Pharmaceutical is expected to gain European Union antitrust approval for its $62 billion acquisition of Shire, a London-based pharmaceutical company, according to Reuters.

Advertisement

At its semiannual policy meeting this month the American Medical Association will consider endorsing a proposal that will allow Americans to purchase medicine from Canada in person as a solution to lowering  prescription drug prices, according to a STAT news…

Janssen Pharmaceuticals, owned by Johnson & Johnson, voluntarily recalled three lots of birth control pills because the medication had incorrect instructions.   

Eli Lilly & Co. posted a net income of $1.15 billion in the third quarter of 2018, more than double the $555.6 million net income the drugmaker earned in the same quarter last year, according to The Wall Street Journal.

QuickChek, a convenience store chain with 159 stores in New Jersey and New York, will close its nine pharmacy departments and transfer all pharmacy files to CVS Health, according to the Asbury Park Press.

Advertisement